Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-2-9
|
pubmed:abstractText |
Formycin B, a C-nucleoside analog of inosine, is not catabolized by human erythrocytes and mouse P388 leukemia cells and is only very inefficiently phosphorylated in these cells. This relative inertness allows the measurement of its transport into and out of the cells uncomplicated by metabolic conversions. We have measured the zero-trans and equilibrium exchange flux of formycin B in these cells by rapid kinetic techniques. The Michaelis-Menten constants and maximum velocities for formycin B transport in both types of cell were similar to those previously reported for uridine and thymidine. Nevertheless, the differential mobility of the substrate-loaded and empty carrier of human erythrocytes was less for formycin B than uridine as substrate. Formycin B influx was inhibited by other nucleosides in accordance with their affinities for the carrier, but unaffected by purines. The inhibition of formycin B influx by nitrobenzylthioinosine and dipyridamole was also identical to that observed with uridine as substrate (IC50 = 10 and 30 nM, respectively). Formycin B accumulated in both types of cell to 30-40% higher concentrations than were present in the medium. This concentrative accumulation was not due to active transport, metabolism or partitioning into membrane lipids. It seems to reflect binding of formycin B to intracellular components, but does not interfere significantly with measurements of its transport.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Dipyridamole,
http://linkedlifedata.com/resource/pubmed/chemical/Formycins,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/formycin B
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
1010
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-15
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2909251-Animals,
pubmed-meshheading:2909251-Antibiotics, Antineoplastic,
pubmed-meshheading:2909251-Biological Transport, Active,
pubmed-meshheading:2909251-Cell Line,
pubmed-meshheading:2909251-Dipyridamole,
pubmed-meshheading:2909251-Formycins,
pubmed-meshheading:2909251-Humans,
pubmed-meshheading:2909251-Kinetics,
pubmed-meshheading:2909251-Leukemia P388,
pubmed-meshheading:2909251-Mathematics,
pubmed-meshheading:2909251-Mice,
pubmed-meshheading:2909251-Nucleosides
|
pubmed:year |
1989
|
pubmed:articleTitle |
Use of formycin B as a general substrate for measuring facilitated nucleoside transport in mammalian cells.
|
pubmed:affiliation |
Department of Microbiology, Medical School, University of Minnesota, Minneapolis 55455.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|